ArticleInternational journal of hematology-oncology and stem cell research2014

Anti-CD20 Antibody is Effective in the Patient with Refractory Amegakaryocytic Thrombocytopenia, 25 Months Follow up.

Mehrzad Mirzania et al.PubMed ↗Full text ↗

No numbers read from the abstract.